DSIP, or delta-sleep-inducing peptide, is a peptide that promotes sleep and relaxation by influencing brain activity, reducing stress hormones, and potentially aiding in pain management. It works by acting on the central nervous system, increasing the release of GABA and reducing the activity of the HPA axis. While studies have shown potential short-term benefits for insomnia and stress, its long-term efficacy for these conditions is still being explored.  
What DSIP does:
Induces sleep: 
DSIP signals the release of GABA, an inhibitory neurotransmitter, which slows brain activity and promotes sleep. 
Reduces stress: 
It helps to regulate the hypocorticosaril-pituitary-adrenal (HPA)axis and can lower cortisol, a stress hormone, according to YouTube users. 
Manages pain: 
DSIP has shown potential for therapeutic use in chronic pain management in some studies. 
Affects endocrine functions: 
It decreases basal corticotropin levels, stimulates luteinizing hormone (LH) and somatoliberin release, and inhibits somatostatin secretion. 
Potential applications:
Insomnia and sleep disorders: 
Studies have explored DSIP for its sleep-inducing properties in patients with various sleep issues. 
Stress and anxiety: 
Its ability to reduce stress hormones makes it a candidate for treating stress and anxiety-related disorders. 
Chronic pain: 
A pilot study suggests potential benefits for individuals experiencing chronic, severe pain.